The Role of Excitotoxicity in Neurodegenerative Disease
- 15 February 1999
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 81 (3) , 163-221
- https://doi.org/10.1016/s0163-7258(98)00042-4
Abstract
No abstract availableKeywords
This publication has 605 references indexed in Scilit:
- Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansionNature Genetics, 1997
- Glutamate Antagonists in Amyotrophic Lateral SclerosisCNS Drugs, 1996
- Apoptosis in the Pathogenesis and Treatment of DiseaseScience, 1995
- Interactions Between N‐Acetylaspartylglutamate and AMPA, Kainate, and NMDA Binding SitesJournal of Neurochemistry, 1994
- Riluzole and experimental parkinsonismNeuroReport, 1994
- FelbamateDrugs, 1993
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993
- Neuron-specific and state-specific differences in calcium homeostasis regulate the generation and degeneration of neuronal architectureNeuron, 1990
- N-Methyl-d-Aspartate Antagonist MK801 Improves Outcome Following Traumatic Spinal Cord Injury in Rats: Behavioral, Anatomic, and Neurochemical StudiesJournal of Neurotrauma, 1988
- Glutamate-preferring receptors regulate the release of D-[3H]aspartate from rat hippocampal slicesNature, 1981